NCT00001540View on ClinicalTrials.gov

The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

April 30, 1996

Study Completion Date

March 31, 2000

Conditions
HIV Infections
Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001540 - The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo | Biotech Hunter | Biotech Hunter